Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05191407
Other study ID # 70904504 /706
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 23, 2020
Est. completion date October 23, 2020

Study information

Verified date January 2022
Source Akdeniz University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Psychological support may be needed to help patients in the face of emotional disturbances that may be associated with the outbreak and to help them accomplish their fear and anxiety. Due to the increasing fear of COVID-19 transmission during the pandemic, patients may develop treatment avoidance behavior in dental practices. If the fear and anxiety levels of the patients can be determined, it may be easy to offer special approaches to them.


Description:

Officially, the first COVID-19 case in Turkey was diagnosed on March 10, 2020. To ensure social isolation, cities were locked down with residents to stay at home to prevent disease transmission. A very large part of the population may experience frustration, stress, and irritability while in isolation. Due to the prolonged lockdown and COVID-19 associated fear, the COVID-19 pandemic, which threatens people's physical health and lives, is likely to trigger a wide variety of psychological problems such as anxiety and depression by increasing their stress levels. The risk of cross-infection in dentistry has been described as considerably high due to close physical contact between dental professionals and patients, and aerosols production during routine dental treatments. In this uncertain process, patients remain undecided about attending their dental appointments. Their concern is associated with the risk of getting infected and transmitting the disease to family members. All these factors may increase the mental stress of patients. The essential purpose of this study is to evaluate the COVID-19 fear and anxiety level, COVID-19 knowledge status, and information sources in dental patients in Turkey during the pandemic period.


Recruitment information / eligibility

Status Completed
Enrollment 301
Est. completion date October 23, 2020
Est. primary completion date October 23, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - willing to participate with providing informed consent; - age =18 years - able to understand and read & write the Turkish language. Exclusion Criteria: - not willing to participate with providing informed consent; - age<18 years - not able to understand and read & write the Turkish language

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Akdeniz University Antalya

Sponsors (1)

Lead Sponsor Collaborator
Zeliha Aytekin

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Al-Rahimi JS, Nass NM, Hassoubah SA, Wazqar DY, Alamoudi SA. Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: A cross-sectional correlational study. — View Citation

Temsah MH, Al-Sohime F, Alamro N, Al-Eyadhy A, Al-Hasan K, Jamal A, Al-Maglouth I, Aljamaan F, Al Amri M, Barry M, Al-Subaie S, Somily AM. The psychological impact of COVID-19 pandemic on health care workers in a MERS-CoV endemic country. J Infect Public Health. 2020 Jun;13(6):877-882. doi: 10.1016/j.jiph.2020.05.021. Epub 2020 May 29. Erratum in: J Infect Public Health. 2020 Oct;13(10):1599. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary fear of COVID-19 The fear of participants is measured by the Turkish validated version of the fear of COVID-19 Scale. last six month ( from the beggining of the pandemic to time of survey)
Primary anxiety The anxiety level of the participants is measured by the Turkish version of Generalized Anxiety Disorder-7 Scale last two weeks
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure